We are excited to share with you our new review article recently published in Frontiers in Immunology! Araujo G, Marian Valencia L, Martin-Ozimek A, Soto Y, Proctor SD. Atherosclerosis: from lipid-lowering and anti-inflammatory therapies to targeting arterial retention of ApoB-containing lipoproteins. Front. Read More …
Listen Now! To our Podcast regarding our recent publication in the Journal of the American Heart Association that research findings on the chP3R99 antibody which has the potential to be effective across many stages of atherosclerosis development. For more Read More …
When you donate to the Cardiovascular Vaccine Project at the University of Alberta you create change for the better. Your donations support atherosclerosis novel antibody research and innovation that seeks truth and solves problems. 100% of your donations goes to supporting our the Read More …
Yosdel Soto, Arletty Hernández, Roger Sarduy, Victor Brito, Sylvie Marleau, Donna F. Vine, Ana M. Vázquez, Spencer D. Proctor. Monoclonal Antibody chP3R99 Reduces Subendothelial Retention of Atherogenic Lipoproteins in Insulin‐Resistant Rats: Acute Treatment Versus Long‐Term Protection as an Idiotypic Vaccine for Atherosclerosis. Journal of the American Heart Association. 27 June Read More …
Gala Araujo, Agata Martin-Ozimek, Leidy Valencia, Yosdel Soto, Spencer Proctor. Immunogenicity of novel variants of the chimeric chP3R99 antiatherogenic antibody in insulin-resistant rats. Poster presentation. Alberta Diabetes Institute (ADI) Research Day 2023, University of Alberta, Edmonton, Alberta, Canada. Gala Araujo, Read More …
Yosdel Soto, Arletty Hernández, Roger Sarduy, Victor Brito, Sylvie Marleau, Donna F. Vine, Ana M. Vázquez, Spencer D. Proctor. Novel chP3R99 mAb reduces subendothelial retention of atherogenic lipoproteins in Insulin-Resistant rats: Acute treatment versus long-term protection as an idiotypic vaccine for atherosclerosis To read the article please click here: https://doi.org/10.1101/2023.08.30.555546
Agata Martin-Ozimek, Gala Araujo, Spencer Proctor, Yosdel Soto. Immunogenicity of A Novel Cardiovascular Therapy: CHP3R99 MAB. 2023 Nutrition Research Poster Symposium, Edmonton, Alberta, March 29, 2023.
Proctor SD, Lopez YS. A Novel Antibody with Vaccine-like Properties to Treat Heart Disease in Diabetes. Scientia. February 2021 “Patients with diabetes mellitus face an increased risk of developing heart disease. The high levels of sugars, lipid and cholesterol associated Read More …
We have now translated our Cardio Vacc Novel Antibody animation video into Mandarin and Spanish.
Animation Series Part 1: NOVEL ANTIBODY
